Celldex Therapeutics CLDX
NASDAQ CLDX
$31.65 -0.53 (-1.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celldex Therapeutics (CLDX) Interest & Investment Income (2012 - 2026)

Updated

Celldex Therapeutics' Interest & Investment Income came in at $7.12 million for Q2 2026, down 1.9% from $7.26 million a year earlier but up 23.8% from the prior quarter.

Analysis

Celldex Therapeutics (CLDX) Interest & Investment Income (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Celldex Therapeutics reported Interest & Investment Income of $25.28 million, down 28.1% year-over-year; for FY2025, it came in at $28.61 million, down 23.1% from FY2024.

  • Interest & Investment Income carries a five-year compound annual growth rate of 64.1% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $37.22 million in FY2024 (+183.8%), $13.11 million in FY2023 (+350.8%), $2.91 million in FY2022 (+476.0%) and $505,000 in FY2021 (-79.0%).
  • The five-year range for quarterly Interest & Investment Income is $145,000 (Q3 2021) to $10.48 million (Q2 2024).
  • Year-over-year, Interest & Investment Income has declined for five consecutive quarters, with growth averaging 27.5% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q4 2022 (growth of 628.1%), and the weakest in Q4 2021 (a decline of 90.1%).
  • Business Quant data shows CLDX's Interest & Investment Income at $5.75 million (Q1 2026), $5.84 million (Q4 2025) and $6.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Celldex Therapeutics 2.48 Bn 2.48 Bn - 7.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.12 Mn
Mar 31, 2026 5.75 Mn
Dec 31, 2025 5.84 Mn
Sep 30, 2025 6.57 Mn
Jun 30, 2025 7.26 Mn
Mar 31, 2025 8.94 Mn
Dec 31, 2024 8.94 Mn
Sep 30, 2024 10.01 Mn
Jun 30, 2024 10.48 Mn
Mar 31, 2024 7.80 Mn
Dec 31, 2023 4.32 Mn
Sep 30, 2023 2.98 Mn
Jun 30, 2023 2.70 Mn
Mar 31, 2023 3.11 Mn
Dec 31, 2022 1.40 Mn
Sep 30, 2022 912,000.00
Jun 30, 2022 392,000.00
Mar 31, 2022 207,000.00
Dec 31, 2021 192,000.00
Sep 30, 2021 145,000.00
API Access

Celldex Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CLDX&period=max&api_key=YOUR_API_KEY